Denmark
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 363.77 B |
Feb. 3, 2025 | USD 81.94 | -2.80% |
|
Denmark |
|
2 |
USD 12.09 B |
Feb. 3, 2025 | USD 190.39 | -3.71% |
|
Denmark |
|
3 |
USD 7.81 B |
Jan. 31, 2025 | USD 130.66 | 2.64% |
|
Denmark |
|
4 |
USD 6.83 B |
Feb. 3, 2025 | USD 96.67 | -5.32% |
|
Denmark |
|
5 |
USD 5.74 B |
Feb. 3, 2025 | USD 6.01 | -1.79% |
|
Denmark |
|
6 |
USD 4.87 B |
Feb. 3, 2025 | USD 18.27 | -2.30% |
|
Denmark |
|
7 |
USD 1.99 B |
Feb. 3, 2025 | USD 25.56 | -6.78% |
|
Denmark |
|
8 |
USD 1.44 B |
Feb. 3, 2025 | USD 88.54 | -3.65% |
|
Denmark |
|
9 |
USD 85.83 M |
Feb. 3, 2025 | USD 0.20 | -4.20% |
|
Denmark |
|
10 |
USD 81.65 M |
Feb. 3, 2025 | USD 0.73 | 4.37% |
|
Denmark |
|
11 |
USD 59.68 M |
Feb. 3, 2025 | USD 4.38 | -2.50% |
|
Denmark |
|
12 |
USD 35.12 M |
Feb. 3, 2025 | USD 0.63 | -4.50% |
|
Denmark |
|
13 |
USD 20.13 M |
Feb. 3, 2025 | USD 0.73 | -11.55% |
|
Denmark |
|
14 |
USD 12.26 M |
Feb. 3, 2025 | USD 1.58 | -5.64% |
|
Denmark |
|
15 |
USD 6.93 M |
Feb. 3, 2025 | USD 2.61 | -4.99% |
|
Denmark |
|
16 |
USD 5.57 M |
Jan. 31, 2025 | USD 2.46 | -0.40% |
|
Denmark |
|
17 |
USD 5.04 M |
Feb. 3, 2025 | USD 0.46 | -2.15% |
|
Denmark |
The Healthcare company in Denmark with the highest Market Capitalization is Novo Nordisk A/S (Copenhagen Stock Exchange: NOVO-B.CO) at USD 363.77 B.
The Healthcare company in Denmark with the lowest Market Capitalization is Danish Aerospace Company A/S (Copenhagen Stock Exchange: DAC.CO) at USD 5.04 M.
The top 10 Healthcare companies in Denmark by Market Capitalization are Novo Nordisk A/S, Genmab A/S, Ascendis Pharma A/S, Zealand Pharma A/S, H. Lundbeck A/S, Ambu A/S, Bavarian Nordic A/S, Gubra A/S, BioPorto A/S and Saniona AB (publ).
The bottom 10 Healthcare companies in Denmark by Market Capitalization are Danish Aerospace Company A/S, Evaxion Biotech A/S, ExpreS2ion Biotech Holding AB (publ), ViroGates A/S, Scandinavian Medical Solutions A/S, Initiator Pharma A/S, FluoGuide A/S, Saniona AB (publ), BioPorto A/S and Gubra A/S.